TISSUE REGENERATION TECHNOLOGIES, LLC
  • Providers
  • About
    • orthogold
    • About Softwave
    • Management
    • Board of Managers
    • Board of Advisors
    • Upcoming Events
  • Research
    • FDA
    • Search
    • SoftWave™ Literature
    • Back, Spine, Nerves
    • Biologic Response
    • Bone Healing
    • Brain, Stroke
    • Cardiology
    • Cancer
    • Cosmetics/Aesthetics
    • Dental
    • Integrative Medicine
    • Modulation of Inflammation
    • Opioid Addiction
    • Organ Regeneration
    • Physics
    • Sports Medicine and Orthopedics >
      • OrthoGold User Guide and Protocols
    • Respiratory/Coronavirus
    • Stem Cells
    • Urology >
      • UroGold IRB User Guide and Protocols
    • Sexual Health
    • Veterinary
    • Wound Care >
      • Wound Care Protocols
    • Research Experts
    • Research Centers
    • Shockwave Summary
  • News
  • Products
    • Cardiology
    • DermaGold100
    • Lithotripsy >
      • Lithotripsy Technical Specifications
      • Lithotripsy F2 Zone Comparison
      • Lithotripsy Imaging
    • Orthopedics >
      • OrthoGold 100™
      • OrthoGold 280™
      • Sport orthopedics and traumatology
    • Urology & Sexual Health
    • Veterinary
    • Wound Care
  • TESTIMONIALS
    • Dr Endorsement Testimonals
    • Cardiology - Stroke
    • Cosmetics
    • Neuropathy
    • Orthopedics
    • Urology & Sexual Health
    • Veterinary
    • Wounds
  • Contact
  • Shop
  • Customer Portal
  • New Page
Tissue Regeneration Technologies: 251 Heritage Walk Woodstock, GA 30188|(404) 402-6844

Extracorporeal Shock Wave Therapy for Breast Cancer-Related Lymphedema: A Pilot Study.

11/18/2019

 
Cebicci MA1, Sutbeyaz ST2, Goksu SS3, Hocaoglu S2, Oguz A3, Atilabey A2.Author information1
Department of Physical Therapy and Rehabilitation, Kayseri Training and Research Hospital, Kayseri, Turkey. Electronic address: maykaccebicci@gmail.com.
2
Department of Physical Therapy and Rehabilitation, Kayseri Training and Research Hospital, Kayseri, Turkey.
3
Department of Medical Oncology, Kayseri Training and Research Hospital, Kayseri, Turkey.AbstractOBJECTIVE:
To investigate the clinical effect of extracorporeal shock wave therapy (ESWT) in patients with secondary lymphedema after breast cancer treatment.
DESIGN:
Prospective clinical pilot study.
SETTING:
Education and research hospital.
PARTICIPANTS:
Women with a diagnosis of lymphedema secondary to breast cancer (N=11).
INTERVENTIONS:
Patients were treated for 12 sessions of ESWT with 2500 impulses each. The treatment frequency was 4Hz in multiple shock mode. The energy flow density during treatment was equal to a working pressure of 2 bar.
MAIN OUTCOME MEASURES:
The primary outcome measure was volumetric measurements. The secondary outcome measures were the short version of the Disabilities of the Arm, Shoulder and Hand Questionnaire (QuickDASH) and the brief version of the World Health Organization Quality of Life (WHOQOL-BREF). Assessments were conducted by the same investigator at baseline, posttreatment, and at 1, 3, and 6 months after treatment for all patients.
RESULTS:
Significant reduction was found in the amount of lymphedema with ESWT treatment in all patients, and this reduction was maintained for 6 months. A statistically significant reduction was observed in volumetric measurements for the follow-up period (P=.001). The mean volume displacement of the affected upper extremity before treatment was 870.45±384.19mL at 6 months, and after the treatment it was 604.54±381.74mL. In addition, improvements were observed in the QuickDASH functional assessment tool and in the physical health domain of the WHOQOL-BREF questionnaire (P=.002 and P=.007, respectively).
CONCLUSIONS:
ESWT was shown to provide a reduction in the amount of lymphedema in patients with lymphedema secondary to breast cancer. Also, a marked improvement was observed in the functional status and quality of life of study patients. Treatment efficacy was maintained in the long term. As a noninvasive, novel, and effective method, ESWT is a promising treatment modality for the treatment of lymphedema, which is a chronic, progressive, and refractory condition.
Copyright © 2016 American Congress of Rehabilitation Medicine. Published by Elsevier Inc. All rights reserved.




Comments are closed.
Picture
  • 251 Heritage Walk 
    Woodstock, GA 30188​
  • info@trtllc.com​
  • (888) 862-6162

    Please join our quarterly newsletter.

Subscribe to Newsletter
  • About
  • Contact Us
  • FAQ's
  • ​FDA 
  • Investors
  • Customer Portal
  • Meetings
  • Partners
  • Patents
  • Providers

OrthoGold100® is FDA 510(k) cleared for the activation of connective tissue, treatment of diabetic foot ulcers & registered for pain reduction and improved blood supply.
© Copyright 2021 Tissue Regeneration Technologies   |   All Rights Reserved
  • Providers
  • About
    • orthogold
    • About Softwave
    • Management
    • Board of Managers
    • Board of Advisors
    • Upcoming Events
  • Research
    • FDA
    • Search
    • SoftWave™ Literature
    • Back, Spine, Nerves
    • Biologic Response
    • Bone Healing
    • Brain, Stroke
    • Cardiology
    • Cancer
    • Cosmetics/Aesthetics
    • Dental
    • Integrative Medicine
    • Modulation of Inflammation
    • Opioid Addiction
    • Organ Regeneration
    • Physics
    • Sports Medicine and Orthopedics >
      • OrthoGold User Guide and Protocols
    • Respiratory/Coronavirus
    • Stem Cells
    • Urology >
      • UroGold IRB User Guide and Protocols
    • Sexual Health
    • Veterinary
    • Wound Care >
      • Wound Care Protocols
    • Research Experts
    • Research Centers
    • Shockwave Summary
  • News
  • Products
    • Cardiology
    • DermaGold100
    • Lithotripsy >
      • Lithotripsy Technical Specifications
      • Lithotripsy F2 Zone Comparison
      • Lithotripsy Imaging
    • Orthopedics >
      • OrthoGold 100™
      • OrthoGold 280™
      • Sport orthopedics and traumatology
    • Urology & Sexual Health
    • Veterinary
    • Wound Care
  • TESTIMONIALS
    • Dr Endorsement Testimonals
    • Cardiology - Stroke
    • Cosmetics
    • Neuropathy
    • Orthopedics
    • Urology & Sexual Health
    • Veterinary
    • Wounds
  • Contact
  • Shop
  • Customer Portal
  • New Page